This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Posted on 26 February 2018 | 3:50 am
TWi Biotechnology gets TFDA nod to treat
BSA bureau (press release)TWi Biotechnology gets TFDA nod to treat Inherited Epidermolysis BullosaBSA bureau (press release)The company announced that it has received approval from the Taiwan Food and Drug Administration (TFDA) to proceed a phase 2 clinical trial of AC-203 for the treatment of inherited Epidermolysis Bullosa (EB). This trial is designed to be a double-blind ...
Posted on 26 February 2018 | 3:46 am
TWi Biotechnology, Inc. Announced Regulatory
TWi Biotechnology, Inc. Announced Regulatory Clearance to Begin Phase 2 Proof-of-Concept Clinical trial of AC-203 ...PR Newswire (press release)TAIPEI, Taiwan, Feb. 26, 2018 /PRNewswire/ -- TWi Biotechnology, Inc. ("TWi Biotech", TWO: 6610), a clinical stage biotechnology company focused on developing inhibitors of inflammasomes, today announced that it has received approval from the Taiwan ...and more »
Posted on 26 February 2018 | 1:00 am
Critical Survey: iShares NASDAQ
Frisco FastballCritical Survey: iShares NASDAQ Biotechnology Index (IBB) vs. Cannae (CNNE)The Ledger GazetteiShares NASDAQ Biotechnology Index logo iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield ...Ferris Capital LLC Increases Holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB)StockNewsTimesParsons Capital Management Inc. RI Increases Stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB)Dispatch TribunalMUFG Americas Holdings Corp Boosts Holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB)Week HeraldFrisco Fastball -The Lincolnian Online -registrarjournal.com -Holdings Channelall 96 news articles »
Posted on 25 February 2018 | 11:38 pm
EMA recommends two orphan drugs for approval
European BiotechnologyEMA recommends two orphan drugs for approvalEuropean BiotechnologyMylotarg was then voluntarily withdrawn from the market after subsequent confirmatory trials failed to verify clinical benefit and demonstrated safety concerns, including a high number of early deaths. The Committee also recommended Alpivab (peramivir ...and more »
Posted on 25 February 2018 | 11:01 pm
Threats Prompt Reallocation of Biotech
The Monsanto Company donated $25,000 to support the Talking Biotech program, a science communication effort that provided on-campus workshops to train scientists about how to engage the public on agricultural biotechnology. The university will reallocate ...
Posted on 27 August 2015 | 5:40 am
ETF Analysis: BioShares Biotechnology
The BioShares Biotechnology Products Fund (Nasdaq: BBP) attempts to reproduce the investment results, before fees and expenses, of the LifeSci Biotechnology Products Index. This index is focused on the common stock of U.S. exchange-listed biotechnology ...
Posted on 27 August 2015 | 4:03 am
International Biotechnology Trust Plc
International Biotechnology Trust Plc (LON:IBT) insider Bouchet ,Veronique acquired 2,500 shares of International Biotechnology Trust Plc stock in a transaction dated Thursday, August 27th. The stock was acquired at an average cost of GBX 493 ($7.72) per ...
Posted on 27 August 2015 | 2:22 am
Novartis Announces Winners of its 12th
The International Biotechnology Leadership Camp (BioCamp) engages students around scientific advances and entrepreneurial opportunities The interactive program brought 70 university students from 24 countries and territories to Novartis headquarters in ...
Posted on 27 August 2015 | 1:56 am
Generex Announces Issuance of Buccal Insulin
WORCESTER, Mass. and TORONTO, Aug. 27, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced the issuance of a white paper on the status of Generex Oral-lyn™, the Company's proprietary buccal insulin spray ...
Posted on 26 August 2015 | 11:49 pm